Vallon Pharmaceuticals (NASDAQ: VLON)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Vallon Pharmaceuticals (NASDAQ: VLON) through any online brokerage.
The latest price target for Vallon Pharmaceuticals (NASDAQ: VLON) was reported by HC Wainwright & Co. on Monday, November 22, 2021. The analyst firm set a price target for 12.00 expecting VLON to rise to within 12 months (a possible 2073.91% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Vallon Pharmaceuticals (NASDAQ: VLON) is $0.552 last updated May 23, 2022, 8:00 PM UTC.
There are no upcoming dividends for Vallon Pharmaceuticals.
Vallon Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, August 9, 2022.
There is no upcoming split for Vallon Pharmaceuticals.
Vallon Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.